This is a preview of subscription content, log in via an institution to check access.
References
S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar, and M. Ali. Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment. J. Biomed. Nanotech. 3:28–44 (2007).
F. Shakeel, S. Baboota, A. Ahuja, J. Ali, M. Aqil, and S. Shafiq. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 8:E104 (2007).
S. Baboota, F. Shakeel, A. Ahuja, J. Ali, and S. Shafiq. Design development and evaluation of novel nanoemulsions formulations for transdermal potential of celecoxib. Acta Pharm. 8:316–332 (2007).
S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar, and M. Ali. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66:227–242 (2007).
S. Yusuf, H. Gerstein, B. Hoogwerf, J. Pogue, J. Bosch, B. H. R. Wolffenbuttel, and B. Zinman. HOPE study investigators, ramipril and the development of diabetes. JAMA. 286:1882–1885 (2001).
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Engl. J. Med. 34:145–153 (2000).
L. Hanysova, M. Václavková, J. Dohnal, and J. Klimeš. Stability of ramipril in the solvents of different pH. J. Pharm. Biomed. Anal. 24:335–342 (2005).
B. L. Hogan, M. Williams, A. Idiculla, T. Veysoglu, and E. Parente. Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules. J. Pharm. Biomed. Anal. 23:637–651 (2000).
Nitin et al. Stable pharmaceutical formulations. U S Patent 0,045,911 (2006).
R. Eyjolfsson. Formulations of Ramipril. W O Patent 2005067887 (2005).
F. Belal, I. A. Al-Zaagi, M. A. Gadkariem, and M. A. Abounassif. A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorthiazide in dosage forms. J. Pharm. Biomed. Anal. 24:335–342 (2001).
Indian Pharmacopoeia. Reagents and solutions. Appendix 13, pp. A144–A145 (1996).
P. P. Constantinides. Lipid microemulsions for improving drug dissolution and oral absorption and biopharmaceutical aspects. Pharm. Res. 12:1561–1572 (1995).
P. P. Constantinides, C. M. Lancaster, J. Marcello, D. C. Chiossone, D. Orner, I. Hidalgo, P. L. Smith, A. B. Sarkahian, S. H. Yiv, and A. J. Owen. Enhanced intestinal absorption of an RGD peptide from water-in-oil microemulsions of different composition and particle size. J. Control. Release. 34:109–116 (1995).
J. Eccleston. Microemulsions. In J. Swarbrick, and J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 1994, pp. 375–421.
P. K. Ghosh, and R. S. R. Murthy. Microemulsions: A potential drug delivery systems. Curr. Drug. Del. 3:167–180 (2006).
M. J. Lawrence, and G. D. Rees. Microemulsion-based media as novel drug delivery systems. Adv. Drug. Deliv. Rev. 45:89–121 (2000).
S. Shafiq, F. Shakeel, S. Talegaonkar, J. Ali, S. Baboota, A. Ahuja, R. K. Khar, and M. Ali. Formulation development and optimization using nanoemulsion technique: A technical note. AAPS PharmSciTech. 8:E28 (2007).
Acknowledgment
The authors are thankful to Nikko Chemicals, Japan and Ranbaxy Research Laboratory, India for providing the gift sample of Sefsol 218 and ramipril base, respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1208/s12249-011-9596-z.
Rights and permissions
About this article
Cite this article
Shafiq, S., Shakeel, F. Enhanced Stability of Ramipril in Nanoemulsion Containing Cremophor-EL: A Technical Note. AAPS PharmSciTech 9, 1097–1101 (2008). https://doi.org/10.1208/s12249-008-9151-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-008-9151-8